Sky-high price of new stem cell therapies is a growing concern – Los Angeles Times
Los Angeles Times |
Sky-high price of new stem cell therapies is a growing concern
Los Angeles Times "If Californians don't have ready access to CIRM-produced stem cell therapies, to me that's a problem," says Paul Knoepfler, a cell biologist at UC Davis and a CIRM grantee. "At some point, someone's going to have to raise their hand and ask, how much … Japan seeks leadership role in stem cell medicine Johns Hopkins researchers explore mysterious, shape-shifting nature of stem cells CIRM's New Stem Cell Bank Up, Running |
